BioNTech is preparing for FDA approval, supported by partnerships and investments from companies like Sigma-Aldrich and Lonza, including facility builds in St. Louis and Madison.
1 report, 1 independent
Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioNTech is preparing for FDA approval, supported by partnerships and investments from companies like Sigma-Aldrich and Lonza, including facility builds in St. Louis and Madison.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BioNTech
Biotechnology company from Germany
Nothing else this week.
-
Sigma-Aldrich
company
Nothing else this week.
- FDA
Coverage
Newest first; wire copies grouped- Pharmaceutical TechnologyADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical companies and manufacturers, including MilliporeSigma (Burlington, US), Sim